BREMEN, Germany--(BUSINESS WIRE)--Early detection of lung cancer helps save lives. In the U.S., screening programs for high-risk groups will be implemented next year; European countries are expected to follow. For imaging centers looking into offering services, medical software specialist MeVis Medical Solutions AG is offering support to help them cope with the vast number of clients, with the implementation of guidelines, and quality requirements.
Lung cancer is the leading cancer killer in both men and women in the United States and elsewhere. It causes more deaths than the next three most common cancers combined (colon, breast, and pancreatic). The prime challenge is that, in most cases, patients present when their condition is symptomatic; at that stage, treatment is difficult and outcomes are less than positive. Early detection can help save lives: results of the U.S. National Lung Screening Trial (NLST) show a 20 percent reduction in mortality thanks to CT screening. The U.S. is now turning to lung screening for high-risk groups to ameliorate this situation while European policymakers are still in the process of finding facts, based on the Dutch-Belgian “Nelson” and further trials. However, European countries are expected to follow suit.
Help employers find you! Check out all the jobs and post your resume.
